ArticleCell reports. Medicine2025

Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis.

Dong-Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.